GBL bill
This article was originally published in The Tan Sheet
Executive Summary
House passes the Hillary J. Farias Date-Rape Prevention Drug Act Oct. 12 by a vote of 423-1. The bill (HR 2130) would classify both gamma butyrolactone and gamma hydroxybutyric acid as controlled substances; it passed the House Commerce Committee by voice vote Aug. 5 (1"The Tan Sheet" Aug. 16, In Brief). Companion legislation introduced in the Senate by Spencer Abraham (R-Mich.) is expected to be the subject of a hearing in the next 10 to 14 days. GBL, sold as a dietary supplement, has been the subject of several FDA warnings; GHB is under scrutiny as a "date rape" drug